Cite

HARVARD Citation

    Petrelli, F. et al. (2016). Early analysis of surrogate endpoints for metastatic melanoma in immune checkpoint inhibitor trials. Medicine. 95 (26), pp. e3997-. [Online]. 
  
Back to record